The store will not work correctly when cookies are disabled.
(1-{[4-(6-Fluoropyridin-3-yl)phenyl]sulfonamide}-2-methylpropyl)phosphonic acid
ID: ALA3752747
Chembl Id: CHEMBL3752747
PubChem CID: 127029507
Max Phase: Preclinical
Molecular Formula: C15H18FN2O5PS
Molecular Weight: 388.36
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)C(NS(=O)(=O)c1ccc(-c2ccc(F)nc2)cc1)P(=O)(O)O
Standard InChI: InChI=1S/C15H18FN2O5PS/c1-10(2)15(24(19,20)21)18-25(22,23)13-6-3-11(4-7-13)12-5-8-14(16)17-9-12/h3-10,15,18H,1-2H3,(H2,19,20,21)
Standard InChI Key: XMXCQGFKYDSJLX-UHFFFAOYSA-N
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 388.36 | Molecular Weight (Monoisotopic): 388.0658 | AlogP: 2.33 | #Rotatable Bonds: 6 |
Polar Surface Area: 116.59 | Molecular Species: ACID | HBA: 4 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 1.49 | CX Basic pKa: ┄ | CX LogP: 1.94 | CX LogD: -0.46 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.52 | Np Likeness Score: -0.95 |
References
1. Beutel B, Daniliuc CG, Riemann B, Schäfers M, Haufe G.. (2016) Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography., 24 (4): [PMID:26810711] [10.1016/j.bmc.2016.01.017] |